已發(fā)表的部分文獻: 標(biāo)題:Social isolation-induced epigenetic changes in midbrain of adult mice.作者:Siuda D, Wu Z, Chen Y, Guo L, Linke M, Zechner U, Xia N, Reifenberg G, Kleinert H, Forstermann U, Li H;雜志名稱:J Physiol Pharmacol 標(biāo)題:Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer.作者:Khanal T, Choi K, Leung YK, Wang J, Kim D, Janakiram V, Cho SG, Puga A, Ho SM, Kim K;雜志名稱:Sci Rep 標(biāo)題:Molecular Basis for Transgenerational Toxicity Induction of Environmental Toxicants or Stresses作者:Wang D;雜志名稱:Molecular Toxicology in Caenorhabditis elegans 標(biāo)題:Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications.作者:Kumar A, Kumari N, Sharma U, Ram S, Singh SK, Kakkar N, Kaushal K, Prasad R;雜志名稱:Sci Rep Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應(yīng)商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。